These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15782137)

  • 1. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
    Park S; Yeung ML; Beach S; Shields JM; Yeung KC
    Oncogene; 2005 May; 24(21):3535-40. PubMed ID: 15782137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.
    Schuierer MM; Bataille F; Hagan S; Kolch W; Bosserhoff AK
    Cancer Res; 2004 Aug; 64(15):5186-92. PubMed ID: 15289323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
    Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma.
    Schuierer MM; Bataille F; Weiss TS; Hellerbrand C; Bosserhoff AK
    Oncol Rep; 2006 Sep; 16(3):451-6. PubMed ID: 16865242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Raf kinase inhibitor protein (RKIP) in health and disease.
    Keller ET; Fu Z; Brennan M
    Biochem Pharmacol; 2004 Sep; 68(6):1049-53. PubMed ID: 15313400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf kinase inhibitory protein inhibits beta-cell proliferation.
    Zhang L; Fu Z; Binkley C; Giordano T; Burant CF; Logsdon CD; Simeone DM
    Surgery; 2004 Sep; 136(3):708-15. PubMed ID: 15349122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
    Hagan S; Garcia R; Dhillon A; Kolch W
    Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C; Marais R
    J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
    Hagan S; Al-Mulla F; Mallon E; Oien K; Ferrier R; Gusterson B; García JJ; Kolch W
    Clin Cancer Res; 2005 Oct; 11(20):7392-7. PubMed ID: 16243812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.
    Keller ET; Fu Z; Brennan M
    J Cell Biochem; 2005 Feb; 94(2):273-8. PubMed ID: 15565643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis.
    Chen Y; Ouyang GL; Yi H; Li MY; Zhang PF; Li C; Li JL; Liu YF; Chen ZC; Xiao ZQ
    J Proteome Res; 2008 Dec; 7(12):5254-62. PubMed ID: 19367706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas.
    Cardile V; Malaponte G; Loreto C; Libra M; Caggia S; Trovato FM; Musumeci G
    Acta Histochem; 2013 Oct; 115(8):795-802. PubMed ID: 23601922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152.
    Kim YK; Ahn SK; Lee M
    Cancer Lett; 2012 Jul; 320(2):215-24. PubMed ID: 22425959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Raf kinase inhibitor protein contributes to macrophage differentiation.
    Schuierer MM; Heilmeier U; Boettcher A; Ugocsai P; Bosserhoff AK; Schmitz G; Langmann T
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1083-7. PubMed ID: 16513087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V 600 E) B-RAF.
    Christensen C; Guldberg P
    Oncogene; 2005 Sep; 24(41):6292-302. PubMed ID: 16007203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells.
    Fan F; Feng L; He J; Wang X; Jiang X; Zhang Y; Wang Z; Chen Y
    Carcinogenesis; 2008 Jun; 29(6):1157-63. PubMed ID: 18515281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway.
    Shin SY; Rath O; Choo SM; Fee F; McFerran B; Kolch W; Cho KH
    J Cell Sci; 2009 Feb; 122(Pt 3):425-35. PubMed ID: 19158341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
    Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
    Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.